dc.contributor.author | Lule, G. N. | |
dc.contributor.author | Okoth, F. | |
dc.contributor.author | Ogutu, E. O. | |
dc.contributor.author | Mwai, S. J. | |
dc.date.accessioned | 2013-05-15T14:48:27Z | |
dc.date.available | 2013-05-15T14:48:27Z | |
dc.date.issued | 1989-05 | |
dc.identifier.citation | East Afr Med J. | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/2791927 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/23350 | |
dc.description.abstract | In an exercise to study the immunogenicity and reactogenicity of the Engerix B vaccine, 160 medical students were screened for Hepatitis B Markers (HBsAg, HBsAb and HBcAb) with a view to vaccinating those that were negative. 18% were HBsAg + ve, 33% were HBsAb + ve and 38% were positive for the HBcAb. These figures were extremely high and obviated the need to vaccinate the students as they begin their clinical years | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Vol. 66(5):315-8.(1989); | |
dc.title | HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital | en |
dc.type | Article | en |
local.publisher | School of Medicine, University of Nairobi | en |